PetVivo to Showcase Veterinary Innovations at Spartan Capital Investor Conference

PetVivo Holdings, Inc. (OTCQX: PETV), a leading biomedical therapeutics company focused on equines and companion animals, will present at the Spartan Capital Securities Second Annual Investor Conference on November 3, 2025, at the Marriott Marquis Hotel in New York City. The event, organized in partnership with B2i Digital, aims to connect innovative growth companies with institutional investors, featuring over 60 carefully selected companies across technology, healthcare, consumer, mining, and precious metals sectors. PetVivo's CEO John Lai will showcase the company's progress and flagship products, including SPRYNG™ with OsteoCushion™ Technology and PrecisePRP®, positioning the conference as a crucial platform for emerging market leaders seeking capital and visibility.

The company's presentation will highlight two groundbreaking veterinary products that represent significant advancements in animal healthcare. SPRYNG with OsteoCushion Technology is an intra-articular injectable veterinary medical device consisting of sterilized, extra-cellular matrix microparticles that integrate with animal joint tissue to restore proper joint mechanics and manage noninfectious joint pain sources like degenerative joint disease and osteoarthritis. Meanwhile, PrecisePRP stands out as a first-in-class, off-the-shelf platelet-rich plasma product that eliminates the need for blood draws or centrifugation, offering veterinarians unprecedented convenience and consistency with each vial containing exactly 4 billion platelets at a concentration of 500,000 platelets per microliter. These innovations demonstrate PetVivo's strategic approach to leveraging human therapies for veterinary applications with accelerated timelines to market.

Spartan Capital Securities CEO John D. Lowry emphasized the conference's mission to bring together high-quality issuers and serious capital providers, while B2i Digital CEO David Shapiro highlighted their commitment to connecting investors with diverse growth companies through both digital marketing and face-to-face engagement. The event will feature main-stage presentations, expert panels, curated one-on-one meetings, and extensive networking sessions, with over 500 institutional and high-net-worth investors expected to attend. For registration details, interested parties can visit the Spartan Capital Investor Conference 2025 Registration page on the B2i Digital website, which serves as a central hub for conference information and participation opportunities.